Alphavirus vectors: development and potential therapeutic applications.
about
Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for FinfishKunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine DevelopmentMolecular cloning, overproduction, purification and biochemical characterization of the p39 nsp2 protease domains encoded by three alphavirusesInhibition of viral replication by ribozyme: mutational analysis of the site and mechanism of antiviral activityDouble subgenomic alphaviruses expressing multiple fluorescent proteins using a Rhopalosiphum padi virus internal ribosome entry site elementCharacterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathwaysComprehensive mapping of common immunodominant epitopes in the eastern equine encephalitis virus E2 protein recognized by avian antibody responses.DNA vaccines for non-infectious diseases: new treatments for tumour and allergy.Viral vector-based therapeutic cancer vaccinesCellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.Prospects for immunisation against Marburg and Ebola viruses.HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in miceGene therapy of mesothelioma.Cellular factors influencing Semliki Forest Virus vector biology.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Intranasal delivery of vaccines against HIV.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.Development of vaccines for Marburg hemorrhagic fever.Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Vaccines: A review of immune-based interventions to prevent and treat disease.Oncolytic Alphaviruses in Cancer Immunotherapy.Evidence for arbovirus dissemination conduits from the mosquito (Diptera: Culicidae) midgut.Rubella virus-like replicon particles: analysis of encapsidation determinants and non-structural roles of capsid protein in early post-entry replication.Packaging of porcine reproductive and respiratory syndrome virus replicon RNA by a stable cell line expressing its nucleocapsid protein.Processing of a pestivirus protein by a cellular protease specific for light chain 3 of microtubule-associated proteins.Analysis of murine B-cell epitopes on Eastern equine encephalitis virus glycoprotein E2.Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon.Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.Regulation of the sequential processing of Semliki Forest virus replicase polyprotein.Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery.Alphaviruses in gene therapySemliki Forest VirusExpression SystemImmunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus
P2860
Q24796792-EB086BC4-2748-431D-955B-FFB6AAF73C07Q26777943-B1AA76B5-DBAD-4846-8DA3-D117770639D0Q27477561-7D2E58F4-83F2-4E59-A9FB-170FC1ABF048Q27488874-1B2BE475-966F-4255-930F-86B37E9E376FQ28236739-34609E72-A623-4C38-995A-5312782B7910Q33750316-77427B10-2B7F-4E0F-BFE7-04FEA42943AFQ33788861-84582B21-B2CC-44BE-91B1-5E6F2D258FA4Q34111604-BF61798E-35B5-4C01-8331-9C885B81A726Q34703631-6B7D210F-BA9A-4E89-ACC5-967149823F0AQ34703643-2E1246C6-993E-4965-AA5D-E6CDD2F9F0BCQ34902499-7DFD966A-007E-44A7-B4A0-BF4E427D0958Q35164804-01F34C76-9E20-4E39-A81C-2FAB66A92056Q35515080-A6365F24-C01D-4C0F-B879-7283DC9769B9Q35946943-9439087B-62DE-4ECF-907A-8C141525D457Q35953762-5AAC4117-306C-4AAD-BE68-1AB02C25A1A8Q36088118-43C8F782-14AA-4B24-AB74-AC30DEC880EDQ36156347-CA90C9B9-0A20-4EFA-8C25-7F1B4340BFD2Q36210859-ADA1A26F-7BAE-452A-8133-018E7D320023Q36288885-4885DE88-9998-4813-A47C-0F261DCFFB77Q36377208-D93BE998-41CC-48A5-A644-9851D3429AF6Q36409054-C497B185-864B-4645-B896-339978C2A97FQ36498186-595CB53B-908F-4653-AE30-A63C2E109783Q36524157-C47A279F-F20C-496E-A7F8-643EA0FB3B3AQ36728793-1FEA8AC7-0E77-4DB7-B862-BBD345824BA7Q36759944-52F1269B-374D-48C0-BCCB-C69CB5EE4B2BQ38199151-1ECF4F0F-6E0A-4DDA-B9AC-2507656A2C28Q38364468-476BD41D-6969-440E-AD64-5563238CB7A6Q39247874-EA637867-675F-4AFF-9373-67322DE5C942Q39407297-0EE389EA-D199-41A9-8500-32F85622C3B4Q39438030-AA044A63-16F0-4F3F-9ABE-A7BD52C869C1Q39515590-29617691-1EFC-4045-B573-F23D41076678Q40556449-0CDA568C-8BAD-4115-8FBD-9BB70F9FFAE9Q42009170-9D54E530-F654-4A26-A3AE-30D4C7B0A0A7Q42119380-BC3FEA03-124D-4D03-A89D-B88E4E3BC52BQ42847157-011D5C43-4A9B-4C2A-8F92-7BD96334FB1EQ44548826-87952647-352A-4834-A5D0-7B49A1115028Q54421725-F5C628ED-5660-4CDA-B0A2-2B7EB6CC128CQ56921680-9E6E23B5-81EE-4C47-90E4-BB43EFFC9A73Q56922178-4BECBFF7-DC38-4EC5-B371-4F5E85DC54DFQ58741516-6B29DE7E-B527-4FC6-9D43-7C6CACF173E6
P2860
Alphavirus vectors: development and potential therapeutic applications.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Alphavirus vectors: development and potential therapeutic applications.
@ast
Alphavirus vectors: development and potential therapeutic applications.
@en
type
label
Alphavirus vectors: development and potential therapeutic applications.
@ast
Alphavirus vectors: development and potential therapeutic applications.
@en
prefLabel
Alphavirus vectors: development and potential therapeutic applications.
@ast
Alphavirus vectors: development and potential therapeutic applications.
@en
P2860
P356
P1476
Alphavirus vectors: development and potential therapeutic applications.
@en
P2093
Schlesinger S
P2860
P304
P356
10.1517/14712598.1.2.177
P407
P577
2001-03-01T00:00:00Z